3Syed A A,Wheatley H A,Badminton M N,et al.Urinary catecholamines and metabolites in the immediate postoperative period following major surgery[J].J Clin Pathol,2004,57(5):548.
4Benn D E,Gimenez-Roqueplo A P,Reilly J R,et al.Clinical presentation and penetrance of pheochromocytoma / paraganglioma syndromes[J].J Clin Endocrinol Metab,2006,91(3):827.
5Eisenhofer G,Goldstein D S,Sullivan P,et al.Biochemical and clinical manifestations of dopamine-producing paragangliomas:utility of plasma methoxytyramine[J].J Clin Endocrinol Metab,2005,90(4):2068.
6Guller U,Turek J,Eubanks S,et al.Detecting pheochromocytoma:defining the most sensitive test[J].Ann Surg,2006,243(1):102.
7Sawka A M,Gafni A,Thabane L,et al.The economic implications of three biochemical screening algorithms for pheochromocytoma[J].J Clin Endocrinol Metab,2004,89(6):2859.
9de Jong WH, de Vries EG, Wolffenbuttel BH, et al. Automated mass spectrometric analysis of urinary free catecholamines using on - line solid phase extraction[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2010,878(19) :1506 - 1512.
10Manickum T. Interferences by anti - TB drugs in a validated HPLC assay for urinary catecholamines and their successful removal[ J]. J Chroma- togr B Analyt Technol Biomed Life Sci, 2008,873 (1) :124 -128.
